IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Cedarburg Seeks to Bounce Back with New Offering

1:43 PM MDT | March 14, 2007 | Alex Scott

Privately owned process development and active pharma ingredient (API) manufacturer Cedarburg Pharmaceuticals (Grafton, WI) says it has been struggling in the highly competitive generic pharmaceuticals market and so is switching its focus toward the ethical pharma market, including projects for ‘virtual’ pharma and major pharma. The company tells CW that it recently raised $3.5 million from private investors and a debt offering to bolster this new direction. The funding will primarily be used to expand the firm’s capabilities in the virtual...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa